Published June 19, 2024
Canada's pharmacies serve millions of patients from across the country every year, and we have a deep understanding of the gaps that currently exist in Canada's pharmacare policies. After several years of dialogue, the first phase of a national, universal pharmacare program was announced in Spring 2024, with the introduction of Bill C-64, an Act respecting pharmacare. The Act describes the Government of Canada’s intent to work with provinces and territories (PTs) to provide single-payer coverage for a number of contraception and diabetes medications.
Our Position Remains Unchanged (please see our 2022 Position Statement below for more detail.)
Refreshed key messages for Spring 2024 are:
Our latest research, reports, member resources and other news related to our advocacy around National Pharmacare can be found at the links below.